DCF — MAINE MEDICAL CENTER
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-506.4M
PV of Cash Flows
$-1.0B
PV of Terminal Value
$-1.6B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.8B | $-79.3M | -4.0% | $-154.0M | $-140.0M |
| Year 2 | $1.8B | $-63.6M | -3.0% | $-140.4M | $-116.1M |
| Year 3 | $1.9B | $-46.8M | -2.0% | $-125.9M | $-94.6M |
| Year 4 | $1.9B | $-38.5M | -2.0% | $-120.1M | $-82.0M |
| Year 5 | $2.0B | $-34.7M | -2.0% | $-118.7M | $-73.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.7B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999979554635
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5